2Yang W, Lu J, Weng J, et al. Prevalence of diabetes among men and women in China[J]. N Engl J Med, 2010, 362(12) :1090- 1101.
3Whiting DR, Guariguata L, Weil C, et al. IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030 [J]. Diabetes Res Clin Pract, 2011, 94(3) : 311-521.
4Li G, Zhang P, Wang J, et al. Cardiovascular mortality, all-cause mortality, and diabetes incidence after lifestyle intervention for people with impaired glucose tolerance in the Da Qing Diabetes Prevention Study: a 23-year follow-up study[J]. Lancet Diabetes Endocrinol, 2014,2(6) :474-480.
5Pan XR, Hu YH, Li GW, et al. Impaired glucose tolerance and its relationship to ECG-indicated coronary heart disease and risk factors among Chinese. Da Qing IGT and diabetes study [ J ]. Diabetes Care, 1993, 16( 1 ) :150-156.
6Pan XR, Li GW, Hu YH, et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study[ J]. Diabetes Care, 1997,20 (4) :537-544.
7Emerging Risk Factors Collaboration, Sarwar N, Gao P, et at. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative recta-analysis of 102 prospective studies[ Jl. Lancet, 2010, 375 (9733) :2215-2222.
8Nakagami T, DECODA Study Group. Hyperglycaemia and mortality from all causes and from cardiovascular disease in five populations of Asian origin[ J]. Diabetologia, 2004, 47 (3) :385- 394.
9Kosaka K, Noda M, Kuzuya T. Prevention of type 2 diabetes by lifesty e intervention: a Japanese trial in IGT males[ J]. Diabetes Res Clin Pract, 2005, 67(2) :152-162.
10de Vegt F, Dekker JM, Ruh6 HG, et al. Hyperglycaemia isassociated with all-cause and cardiovascu|ar mortality in the Hoom population : the Hoom Study[ J]. Diabetologia, 1999,42 ( 8 ) :925- 931.
